리시노프릴 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.3%의 CAGR로 24억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 고혈압 및 심혈관질환의 유병률 증가, 제네릭 의약품 및 비용 효율성, 인식 제고 및 조기 진단, 효과적인 치료에 대한 수요 증가, 고령화 등에 기인하는 것으로 추정됩니다. 예측 기간 동안 주요 동향으로는 약물전달의 혁신, 환자 중심의 약물전달 접근법 강화의 필요성, 비용 효율적인 솔루션에 대한 수요, 심부전 치료에 대한 수요, 당뇨병성 신장 질환에 대한 효과적인 치료법에 대한 수요 등이 있습니다.
심혈관질환의 유병률 증가는 향후 리시노프릴 시장의 성장을 촉진할 것으로 예상됩니다. 심혈관질환(CVD)은 심장과 혈관에 영향을 미치는 다양한 질환을 말합니다. 이러한 질환의 발병률 증가는 인구 증가, 고령화, 위험 요인, 효과적인 예방 및 치료 전략의 미흡한 실행 등의 요인에 기인합니다. 리시노프릴은 주로 혈압을 낮추고 심장과 신장의 부담을 줄여 심혈관질환 관리에 도움을 줍니다. 안지오텐신II의 생성을 억제하고, 혈관 확장을 촉진하며, 혈액량을 감소시키고, 장기를 손상으로부터 보호함으로써 효과를 발휘합니다. 예를 들어, 2024년 5월 싱가포르에 본부를 둔 비영리단체인 싱가포르 심장재단(SHF)은 허혈성 심장질환으로 인한 사망자 수가 5,302명으로 2022년 5,290명에서 소폭 증가했다고 보고했습니다. 따라서 심혈관질환의 유병률 증가가 리시노프릴 시장의 성장을 촉진하고 있습니다.
고혈압 유병률의 증가는 리시노프릴 시장을 견인할 것으로 예상됩니다. 고혈압은 동맥벽에 대한 혈액의 힘이 항상 너무 높은 상태입니다. 건강에 해로운 식습관, 좌식 생활습관, 고령화, 장기적인 스트레스 등의 요인이 고혈압 유병률 증가에 기여하고 있습니다. 리시노프릴은 안지오텐신 II의 형성을 억제하여 혈관을 이완시키고 혈액량을 감소시켜 혈압을 낮춤으로써 고혈압을 효과적으로 관리합니다. 예를 들어, 세계보건기구(WHO)는 2023년 3월, 전 세계 30-79세 성인 중 약 12억 8,000만 명이 고혈압을 앓고 있다고 보고했습니다. 따라서 고혈압 유병률의 증가는 리시노프릴 시장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 리시노프릴 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 리시노프릴 시장 : 성장률 분석
- 세계의 리시노프릴 시장 실적 : 규모와 성장, 2019-2024
- 세계의 리시노프릴 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 리시노프릴 전체 시장(TAM)
제6장 시장 세분화
- 세계의 리시노프릴 시장 : 브랜드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Zestoretic
- Prinivil
- Zestril
- 기타 브랜드
- 세계의 리시노프릴 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 고혈압
- 심부전
- 심장 발작
- 뇌졸중
- 당뇨병성 신장병
- 기타 질병
- 세계의 리시노프릴 시장 : 투여량별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 정제
- 액체
- 기타 투여량
- 세계의 리시노프릴 시장 : 인구 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 아동
- 성인
- 세계의 리시노프릴 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 전문 클리닉
- 기타 최종사용자
- 세계의 리시노프릴 시장, Zestoretic 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 다양한 제형
- Zestoretic 제네릭 의약품
- 세계의 리시노프릴 시장, Prinivil 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 다양한 제형
- Prinivil 제네릭 의약품
- 세계의 리시노프릴 시장, Zestril 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 다양한 제형
- Zestril 제네릭 의약품
- 세계의 리시노프릴 시장, 기타 브랜드 유형별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 국제 브랜드 베리에이션
- 복합 의약품 제제
제7장 지역별·국가별 분석
- 세계의 리시노프릴 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 리시노프릴 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 리시노프릴 시장 : 경쟁 구도
- 리시노프릴 시장 : 기업 개요
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- Vitaris Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Teva Pharmaceutical Industries Limited
- Bausch Health Companies Inc.
- Hetero Ltd.
- Sun Pharmaceutical Industries Limited
- Aurobindo Pharma Ltd.
- Cipla Inc.
- Hikma Pharmaceutical Plc
- Apotex Inc.
- Amneal Pharmaceutical Inc.
- Lupin Ltd.
- Zhejiang Huahai Pharmaceutical Co. Ltd.
- Metrochem API Private Limited
- Calyx Chemicals & Pharmaceuticals Limited
- Farmhispania Group
- Zydus Cadila Healthcare Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 리시노프릴 시장 2029 : 새로운 기회를 제공하는 국가
- 리시노프릴 시장 2029 : 새로운 기회를 제공하는 부문
- 리시노프릴 시장 2029 : 성장 전략
제36장 부록
ksm
Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It works by reducing certain chemicals that tighten blood vessels, facilitating smoother blood flow and improving the heart's pumping efficiency. Lisinopril is prescribed for adults to treat congestive heart failure and to increase survival rates after a heart attack.
The main brands of lisinopril include Zestoretic, Prinivil, Zestril, among others. Zestoretic is a combination medication containing lisinopril, an ACE inhibitor, and hydrochlorothiazide, a thiazide diuretic. It is used to treat conditions such as hypertension, heart failure, heart attacks, strokes, diabetic kidney disease, among others. It is available in various forms such as tablets and liquid, and is prescribed to different populations including children and adults. These medications are used by various end-users such as hospitals, specialty clinics, and others.
The lisinopril market research report is one of a series of new reports from The Business Research Company that provides lisinopril market statistics, including lisinopril industry global market size, regional shares, competitors with a lisinopril market share, detailed lisinopril market segments, market trends, and opportunities, and any further data you may need to thrive in the lisinopril industry. This lisinopril market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lisinopril market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increased accessibility, lifestyle shifts, increased screening programs, increased accessibility of generic lisinopril, and increased patient adherence.
The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population. Major trends in the forecast period include innovations in drug delivery, need for enhanced and patient-centric drug delivery approaches, demand for cost-effective solutions, demand for effective treatments for heart failure, and demand for effective treatments for diabetic kidney disease.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the lisinopril market in the future. Cardiovascular diseases (CVDs) refer to a variety of conditions that affect the heart and blood vessels. The rising incidence of these diseases can be attributed to factors such as population growth, aging, risk factors, and the inadequate implementation of effective prevention and treatment strategies. Lisinopril aids in managing cardiovascular diseases primarily by lowering blood pressure and reducing the strain on the heart and kidneys. It works by inhibiting the production of angiotensin II, promoting blood vessel dilation, reducing blood volume, and protecting organs from damage. For example, in May 2024, the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, reported 5,302 deaths from ischemic heart diseases, a slight increase from 5,290 deaths in 2022. Therefore, the growing prevalence of cardiovascular diseases is fueling the growth of the lisinopril market.
The growing prevalence of hypertension is expected to boost the lisinopril market. Hypertension, or high blood pressure, is a condition where the force of blood against artery walls is consistently too high. Factors such as an unhealthy diet, sedentary lifestyle, aging population, and long-term stress contribute to the increasing prevalence of hypertension. Lisinopril effectively manages hypertension by blocking the formation of angiotensin II, leading to blood vessel relaxation, reduced blood volume, and lower blood pressure. For instance, the World Health Organization reported in March 2023 that around 1.28 billion adults aged 30-79 worldwide had hypertension. Therefore, the increasing prevalence of hypertension is driving the lisinopril market.
In January 2024, Sun Pharmaceutical Industries Limited, an Indian pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd for $347.73 million. This acquisition allows Sun Pharma to expand its portfolio by incorporating Taro's expertise in generic and specialty medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Taro Pharmaceutical Industries Ltd, a US-based company, offers lisinopril.
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lisinopril market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lisinopril market consists of sales of prinivil, qbrelis, zestoretic, zestril and apo-lisinopril. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lisinopril Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lisinopril market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lisinopril ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lisinopril market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
- 2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
- 3) By Dosage: Tablet; Liquid; Other Dosages
- 4) By Population Type: Children; Adults
- 5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
- Subsegments:
- 1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
- 2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
- 3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
- 4) By Other Brands: International Brand Variants; Combination Drug Formulations
- Companies Mentioned: Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; AstraZeneca Plc; Vitaris Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lisinopril Market Characteristics
3. Lisinopril Market Trends And Strategies
4. Lisinopril Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Lisinopril Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lisinopril PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lisinopril Market Growth Rate Analysis
- 5.4. Global Lisinopril Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lisinopril Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lisinopril Total Addressable Market (TAM)
6. Lisinopril Market Segmentation
- 6.1. Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Zestoretic
- Prinivil
- Zestril
- Other Brands
- 6.2. Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypertension
- Heart Failure
- Heart Attack
- Strokes
- Diabetic Kidney Disease
- Other Diseases
- 6.3. Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablet
- Liquid
- Other Dosages
- 6.4. Global Lisinopril Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Children
- Adults
- 6.5. Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Other End-Users
- 6.6. Global Lisinopril Market, Sub-Segmentation Of Zestoretic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Different Dosage Forms
- Generic Versions Of Zestoretic
- 6.7. Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Different Dosage Forms
- Generic Versions Of Prinivil
- 6.8. Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Different Dosage Forms
- Generic Versions Of Zestril
- 6.9. Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- International Brand Variants
- Combination Drug Formulations
7. Lisinopril Market Regional And Country Analysis
- 7.1. Global Lisinopril Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lisinopril Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lisinopril Market
- 8.1. Asia-Pacific Lisinopril Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lisinopril Market
- 9.1. China Lisinopril Market Overview
- 9.2. China Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lisinopril Market
- 10.1. India Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lisinopril Market
- 11.1. Japan Lisinopril Market Overview
- 11.2. Japan Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lisinopril Market
- 12.1. Australia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lisinopril Market
- 13.1. Indonesia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lisinopril Market
- 14.1. South Korea Lisinopril Market Overview
- 14.2. South Korea Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lisinopril Market
- 15.1. Western Europe Lisinopril Market Overview
- 15.2. Western Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lisinopril Market
- 16.1. UK Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lisinopril Market
- 17.1. Germany Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lisinopril Market
- 18.1. France Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lisinopril Market
- 19.1. Italy Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lisinopril Market
- 20.1. Spain Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lisinopril Market
- 21.1. Eastern Europe Lisinopril Market Overview
- 21.2. Eastern Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lisinopril Market
- 22.1. Russia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lisinopril Market
- 23.1. North America Lisinopril Market Overview
- 23.2. North America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lisinopril Market
- 24.1. USA Lisinopril Market Overview
- 24.2. USA Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lisinopril Market
- 25.1. Canada Lisinopril Market Overview
- 25.2. Canada Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lisinopril Market
- 26.1. South America Lisinopril Market Overview
- 26.2. South America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lisinopril Market
- 27.1. Brazil Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lisinopril Market
- 28.1. Middle East Lisinopril Market Overview
- 28.2. Middle East Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lisinopril Market
- 29.1. Africa Lisinopril Market Overview
- 29.2. Africa Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lisinopril Market Competitive Landscape And Company Profiles
- 30.1. Lisinopril Market Competitive Landscape
- 30.2. Lisinopril Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Vitaris Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Lisinopril Market Other Major And Innovative Companies
- 31.1. Teva Pharmaceutical Industries Limited
- 31.2. Bausch Health Companies Inc.
- 31.3. Hetero Ltd.
- 31.4. Sun Pharmaceutical Industries Limited
- 31.5. Aurobindo Pharma Ltd.
- 31.6. Cipla Inc.
- 31.7. Hikma Pharmaceutical Plc
- 31.8. Apotex Inc.
- 31.9. Amneal Pharmaceutical Inc.
- 31.10. Lupin Ltd.
- 31.11. Zhejiang Huahai Pharmaceutical Co. Ltd.
- 31.12. Metrochem API Private Limited
- 31.13. Calyx Chemicals & Pharmaceuticals Limited
- 31.14. Farmhispania Group
- 31.15. Zydus Cadila Healthcare Ltd.
32. Global Lisinopril Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lisinopril Market
34. Recent Developments In The Lisinopril Market
35. Lisinopril Market High Potential Countries, Segments and Strategies
- 35.1 Lisinopril Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lisinopril Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lisinopril Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
